ArticleScientific reports2025
3D printing of stents via two-photon polymerization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hydrogel-Based Micro/Nanorobots for Advanced Biomedical Applications.Gels (Basel, Switzerland) · 2026Review
- Recent Advances in 3D-Printed Bioresorbable Vascular Stents: Toward Patient-Specific, Novel-Structured, Functional, and Smart Devices.ACS omega · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stents are medical devices used to treat the narrowing of the blood vessel, most commonly caused by atherosclerosis. Currently used bare-metal, drug-eluting stents are limited in size and architectural complexity, and there are a few risks associated with these medical devices. In some cases stents can cause thrombosis or even death. Furthermore, said risk increases while stenting relatively small vessels. This paper shows that vascular stents for relatively small vessels and/or for patient-specific stenting applications can be printed using two-photon polymerization (2PP). 2PP is an additive manufacturing technique with sub-μm resolution and unlimited 3D geometry potential. These capabilities were used to produce stents for small blood vessels, which are 5 mm tall and 0.7 or 0.9 mm in diameter, with 3D struts as thin as 50 μm. Several novel approaches were introduced to accommodate the printing of such a structure like voxel elongation and printing in stereolithography-like vat-sample holder configuration. Furthermore, the produced stents were tested mechanically proving their mechanical resilience to most common types of mechanical deformations. Experimental results were also compared to mathematical modeling, showing excellent agreement, hinting at the possibility of designing and testing complex micro-stent geometries before fabrication in silico. Finally, biocompatibility experiments were performed, in which rats survived the 7-day incubation period and showed no significant biocompatibility issues. Overall, the presented work gives an outlook on all aspects related to the 3D printing of stents - design, manufacturing, mechanical, and biological testing. We show that 2PP aligns very well with all these aspects and is a promising technique for the mass manufacturing of vascular stents for small vessels or specifically for the patient.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.